ClinicalTrials.Veeva

Menu
D

Dermatologists of Southwest Ohio | Mason, OH

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Baricitinib
Upadacitinib
LY3009104
Ixekizumab
Humira®
CTP-543
ABP 654
Cedirogant
ABP 501
Guselkumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 12 total trials

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata (BRAVE-AA2)

The reason for this study is to see if baricitinib is safe and effective in adults with severe or very severe alopecia areata (AA).

Active, not recruiting
Alopecia Areata
Drug: Baricitinib
Drug: Placebo
Locations recently updated

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (...

Enrolling
Hidradenitis Suppurativa
Drug: Upadacitinib
Drug: Placebo

Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and fa...

Enrolling
Alopecia Areata
Drug: Upadacitinib
Drug: Placebo

Trial sponsors

AbbVie logo
Lilly logo
Amgen logo
Concert Pharmaceuticals logo
E
R

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems